These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 7842711)
1. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model. Gordon YJ; Romanowski EG; Araullo-Cruz T Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711 [TBL] [Abstract][Full Text] [Related]
2. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model. Romanowski EG; Bartels SP; Gordon YJ Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596 [TBL] [Abstract][Full Text] [Related]
3. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model. Romanowski EG; Araullo-Cruz T; Gordon YJ Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):253-7. PubMed ID: 9019458 [TBL] [Abstract][Full Text] [Related]
4. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Gordon YJ; Romanowski EG; Araullo-Cruz T Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596 [TBL] [Abstract][Full Text] [Related]
5. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis. Maudgal PC; De Clercq E Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. De Clercq E Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600 [TBL] [Abstract][Full Text] [Related]
8. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis. Kaufman HE; Varnell ED; Thompson HW Arch Ophthalmol; 1998 Jun; 116(6):777-80. PubMed ID: 9639447 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model. Romanowski EG; Gordon YJ Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):460-3. PubMed ID: 10670476 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis. Asbell PA; Epstein SP; Wallace JA; Epstein D; Stewart CC; Burger RM Cornea; 1998 Sep; 17(5):550-7. PubMed ID: 9756451 [TBL] [Abstract][Full Text] [Related]
11. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model. Romanowski EG; Gordon YJ; Araullo-Cruz T; Yates KA; Kinchington PR Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1812-5. PubMed ID: 11431446 [TBL] [Abstract][Full Text] [Related]
12. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Romanowski EG; Yates KA; Teuchner B; Nagl M; Irschick EU; Gordon YJ Invest Ophthalmol Vis Sci; 2006 May; 47(5):2021-6. PubMed ID: 16639011 [TBL] [Abstract][Full Text] [Related]
13. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312 [TBL] [Abstract][Full Text] [Related]
14. Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model. Romanowski EG; Gordon YJ Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):158-62. PubMed ID: 11133861 [TBL] [Abstract][Full Text] [Related]
15. Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1. Chatterjee S; Burns P; Whitley RJ; Kern ER Antiviral Res; 1992 Sep; 19(3):181-92. PubMed ID: 1332603 [TBL] [Abstract][Full Text] [Related]
16. In Vitro and In Vivo Evaluation of Cidofovir as a Topical Ophthalmic Antiviral for Ocular Canine Herpesvirus-1 Infections in Dogs. Ledbetter EC; Spertus CB; Pennington MR; Van de Walle GR; Judd BE; Mohammed HO J Ocul Pharmacol Ther; 2015 Dec; 31(10):642-9. PubMed ID: 26418618 [TBL] [Abstract][Full Text] [Related]
17. The treatment of herpes simplex virus epithelial keratitis. Wilhelmus KR Trans Am Ophthalmol Soc; 2000; 98():505-32. PubMed ID: 11190039 [TBL] [Abstract][Full Text] [Related]
18. Timolol induces HSV-1 ocular shedding in the latently infected rabbit. Hill JM; Shimomura Y; Dudley JB; Berman E; Haruta Y; Kwon BS; Maguire LJ Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):585-90. PubMed ID: 3030959 [TBL] [Abstract][Full Text] [Related]
19. The Topical Novel Formulations of Interferon α-2в Effectively Inhibit HSV-1 Keratitis in the Rabbit Eye Model and HSV-2 Genital Herpes in Mice. Ivanina A; Leneva I; Falynskova I; Glubokova E; Kartashova N; Pankova N; Korovkin S; Svitich O Viruses; 2024 Jun; 16(6):. PubMed ID: 38932280 [TBL] [Abstract][Full Text] [Related]
20. Trifluridine decreases ocular HSV-1 recovery, but not herpetic lesions after timolol iontophoresis. Rootman DS; Hill JM; Haruta Y; Reidy JJ; Kaufman HE Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):678-83. PubMed ID: 2539342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]